Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Opioids are the most effective analgesics used in the clinical management of cancer pain or non-cancer pain. However, chronic opioids therapy can cause many side effects including respiratory depression, nausea, sedation, itch, constipation, analgesic tolerance, hyperalgesia, high addictive potentia...
Saved in:
Main Authors: | Li Zhang (Author), Jiang-Tao Zhang (Author), Lihua Hang (Author), Tong Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential
by: Renjie Xu, et al.
Published: (2024) -
Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
by: Keith M. Olson, et al.
Published: (2023) -
Mu-opioid receptor expression in multibacillary leprosy
by: Patrícia Elizabeth Pignataro, et al.
Published: (2019) -
μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis
by: Minoru Hojo, et al.
Published: (2008) -
Functional selectivity of EM-2 analogs at the mu-opioid receptor
by: Justyna Piekielna-Ciesielska, et al.
Published: (2023)